Patrick Burnett

Patrick Burnett

Company: Arcutis Therapeutics

Job title: Senior Vice President & Chief Medical Officer

Seminars:

Exploring the Potential for JAK1 Selectivity in Autoimmune Dermatological Conditions 1:15 pm

Overcoming pre-clinical hurdles in dermatology to enable topical JAK inhibitor development Considering route of delivery and the implications on safety and efficacy Preparing a JAK inhibitor pipeline for transition from pre-clinic to phase 1 trialsRead more

day: Day One

PANEL DISCUSSION – The Road Ahead: Topicals vs Orals vs Alternative Delivery Methods 9:30 am

Exploring the JAK inhibitor drug development landscape and weighing the merit of pursuing topical vs oral vs alternative application Considering the cost concerns and systemic effects associated with oral and injectable delivery systems whilst discussing the small potential for off-target effects in topical creams Discussing the need to equate disease severity and quality of life…Read more

day: Day One

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.